Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Baudax Bio Q3 EPS $(2.47) Up From $(7.00) YoY

Baudax Bio Q3 EPS $(2.47) Up From $(7.00) YoY

Baudax Bio (NASDAQ:BXRX) reported quarterly losses of $(2.47) per share. This is a 64.71 percent increase over losses of $(7.00) per share from the same period last year.

byBenzinga Newsdesk

November 8, 2022

1 minute read

Baudax Bio (NASDAQ:BXRX) reported quarterly losses of $(2.47) per share. This is a 64.71 percent increase over losses of $(7.00) per share from the same period last year.

Alphabet, Meta Platforms And 3 Stocks To Watch Heading Into Thursday

By Avi Kapoor

April 25, 8:45 AM

With U.S. stock futures trading lower this morning on Thursday, some of the stocks that may grab investor…

CAT

Canaccord Genuity Maintains Buy on Sprout Social, Raises Price Target to $70

By Benzinga Newsdesk

February 22, 9:59 AM

Canaccord Genuity analyst David Hynes maintains Sprout Social (NASDAQ:SPT) with a Buy and raises the price target from $65 to $70.

SPT

Huize Authorized US$5M Share Repurchase Program

By Charles Gross

March 17, 5:01 AM

Huize Holding Limited, ("Huize", the "Company" or "we") (NASDAQ: HUIZ), a leading digital insurance product and service platform for new generation consumers in China, today announced that its Board of Directors ("the Board") has authorized a share repurchase program under which Huize may repurchase up to US$5 million of its C

HUIZ